Latest News & Updates

Breaking News

  • 13 minutes ago

  • Mrudula Kulkarni

Sun Pharma amongst 2026 S&P Dow Jones Best-in-Class World Index
Breaking News
FDA Finalizes Digital Health Technology Guidance Reshaping Remote Data Acquisition in Clinical Trials

Simantini Singh Deo

Other trending news you may like to read

Sun Pharma amongst 2026 S&P Dow Jones Best-in-Class World Index

Sun Pharma joins the 2026 S&P Dow Jones Best-in-Class World Index, one of 317 global companies and 25 from India recognised for industry-leading sustainability performance.

Mrudula Kulkarni

Pharma Now

FDA Finalizes Digital Health Technology Guidance Reshaping Remote Data Acquisition in Clinical Trials

FDA's final DHT guidance sets binding expectations for remote data acquisition in clinical trials, affecting protocol design and submission strategy.

Simantini Singh Deo

Pharma Now

FDA Refreshes IND Safety Reporting Guidance Under 21 CFR 312.32 for IND Sponsors

FDA updates its IND safety reporting resource, clarifying 21 CFR 312.32 thresholds, timelines, and submission requirements for active IND sponsors.

Simantini Singh Deo

Pharma Now

FDA Launches Guidance Snapshot Pilot Covering Master Protocols and Bayesian Methodology Drafts

FDA's Guidance Snapshot Pilot debuts with Master Protocols and Bayesian Methodology drafts, offering regulatory teams structured access to cross-cutting clinical trial guidance.

Simantini Singh Deo

Pharma Now